Other ligands, including fibrinogen-like protein 1 (FGL1), galectin-3 (Gal-3), and liver sinusoidal endothelial cell lectin (LSECtin), have been identified to bind with LAG-3, thereby suppressing CD8-mediated anti-tumor responses [62,63,64]. The gene discussed is LAG3; the disease is neoplasm.